Federal Judge Bars Plaintiffs From Adding GSK Entities to Suit
December 16, 2008
DOCUMENTS
- Opinion
OKLAHOMA CITY - In a Paxil injury case, an Oklahoma federal judge has denied the plaintiffs' request to add as defendants GlaxoSmithKline's parent company and GSK's research and development division, ruling that neither entity was a "manufacturer" of the drug and thus cannot be held liable under Oklahoma law. Hayes v. GlaxoSmithKline, No. 07-0682 (E.D. Okla.).
The Nov. 20 opinion was issued by Chief Judge Claire V. Eagan of the U.S. District Court for the Eastern District of Oklahoma.
In November 2007, Jennifer and Justin Hayes sued GSK individually and on behalf of their child, alleging that Jennifer's use of …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach